The Relation of Haplotype ATP-binding Cassette B1 and Glutathione S-transferase P1 A313G Genes with Hematological Toxicity in Indonesian Breast Cancer Patients Receiving Chemotherapy
- PMID: 35402005
- PMCID: PMC8976885
- DOI: 10.5001/omj.2022.36
The Relation of Haplotype ATP-binding Cassette B1 and Glutathione S-transferase P1 A313G Genes with Hematological Toxicity in Indonesian Breast Cancer Patients Receiving Chemotherapy
Abstract
Objectives: Hematological toxicity induced by chemotherapy is known to be caused by multiple factors, including genetic factors such as polymorphisms. The polymorphisms may occur in drug efflux transporter proteins and enzymes involved in drug metabolism. We investigate the incidence of hematological toxicities and their relation to the haplotype ATP-binding cassette B1 (ABCB1) which were polymorphisms of C1236T, C3435T, G2677T, and glutathione S-transferase P1 (GSTP1) A313G genes in Indonesian breast cancer patients who received anthracycline during chemotherapy.
Methods: This retrospective cohort study was conducted on 138 breast cancer patients who underwent three cycles of chemotherapy in H. Adam Malik Hospital, Medan, Indonesia, who satisfied the inclusion criteria. The DNA of these patients was extracted from the peripheral leukocytes. Single nucleotide polymorphism (SNP) ABCB1 and GSTP1 were examined by the polymerase chain reaction-restriction fragment length polymorphism method. Data on patient characteristics and the incidence of hematological toxicity after each of the three cycles of chemotherapy were obtained from the medical records. The variations in absolute neutrophil count (ANC) and anemia were analyzed using the Friedmann test and the Wilcoxon signed-rank test. The Kruskal-Wallis test was used to investigate the association of ABCB1 and GSTP1 polymorphisms with anemia and neutropenia. The frequency distributions of genotypes and alleles were determined using the Hardy-Weinberg Equilibrium (HWE).
Results: Post the chemotherapy cycles, there was decrease in ANC (Mean±SD: 5 644.4±2 962.5 mm3 vs. 3 034.8±2 049.6 mm3) and increase in anemia (12.1±1.5 g/dL vs. 11.2± 1.3 g/dL) (p < 0.050 for each). No relation was observed between ABCB1 polymorphism, either in each SNP or in the form of haplotype (the combination of more than one SNP), and the incidence of anemia and neutropenia (p > 0.050). There was also no correlation between GSTP1 polymorphisms, anemia and neutropenia incidence (p > 0.050). The ABCB1 and GSTP1 genotypes and alleles frequency distribution showed no deviation from HWE (p > 0.050).
Conclusions: Indonesia breast cancer patients who underwent three cycles of chemotherapy demonstrated susceptibility to hematological toxicity by developing side effects such as anemia and neutropenia. However, no relationship was found between hematological toxicity and ABCB1 and GSTP1 polymorphisms.
Keywords: ABCB1 Protein; Breast Cancer; Chemotherapy; GSTP1 Protein, Human; Polymorphism, Gene; Toxicity.
The OMJ is Published Bimonthly and Copyrighted 2022 by the OMSB.
Similar articles
-
Influence of (C1236T and C3435T) Polymorphisms of ABCB1 Gene on Chemotherapy Treatment Outcome and Toxicity in Breast Cancer Patients.Asian Pac J Cancer Prev. 2024 May 1;25(5):1567-1577. doi: 10.31557/APJCP.2024.25.5.1567. Asian Pac J Cancer Prev. 2024. PMID: 38809628 Free PMC article.
-
GSTP1 and ABCB1 Polymorphisms Predicting Toxicities and Clinical Management on Carboplatin and Paclitaxel-Based Chemotherapy in Ovarian Cancer.Clin Transl Sci. 2021 Mar;14(2):720-728. doi: 10.1111/cts.12937. Epub 2020 Dec 16. Clin Transl Sci. 2021. PMID: 33326171 Free PMC article.
-
ABCB1 c.3435C>T polymorphism is associated with platinum toxicity: a preliminary study.Cancer Chemother Pharmacol. 2019 Apr;83(4):803-808. doi: 10.1007/s00280-019-03794-6. Epub 2019 Feb 22. Cancer Chemother Pharmacol. 2019. PMID: 30796464
-
Association between Genetic Polymorphism of GSTP1 and Toxicities in Patients Receiving Platinum-Based Chemotherapy: A Systematic Review and Meta-Analysis.Pharmaceuticals (Basel). 2022 Apr 1;15(4):439. doi: 10.3390/ph15040439. Pharmaceuticals (Basel). 2022. PMID: 35455437 Free PMC article. Review.
-
SNP's use as a potential chemotoxicity stratification tool in breast cancer: from bench to clinic.Funct Integr Genomics. 2025 Apr 22;25(1):93. doi: 10.1007/s10142-025-01602-4. Funct Integr Genomics. 2025. PMID: 40261508 Review.
References
-
- World Health Organization. Cancer country profile. [cited 2021 Mar 10]. Available from: http://www.who.int/cancer/country-profiles/en/.
-
- World Health Organization. Source: Globocan 2020. [cited 2021 Mar 10]. Available from: https://gco.iarc.fr/today/data/factsheets/populations/360-indonesia-fact....
-
- Syarifah S, Siregar KB, Siregar Y. Association of ATP-binding cassette sub-family B member 1 gene C3435T polymorphism with neutropenia in breast cancer patients treated with chemotherapy. Med J Indones 2016;25(3):156-162 .10.13181/mji.v25i3.1326 - DOI
-
- Shahrasbi A, Armin A, Ardebili A, Rafie KS, Ansari M. Hematologic adverse effects following systemic chemotherapy. J Oncol Med & Pract 2017;2(1):110.
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous